References
- Willemze R, Beljaards RC. Spectrum of primary cutaneous CD30 (Ki-l)-positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment. J Am Acad Dermatol 1993; 28: 973–80
- Gianotti R, Alessi E, Cavicchini S. Primary cutaneous pleomorphic T-cell lymphoma expressing CD30 antigen. Am J Dermatopathol 1991; 13: 503–8
- Gerard-Marchant R, Hamlin I, Lennert K, et al. Classification of non-Hodgkin's lymphomas. Lancet 1974; 2: 406–8
- Cordell J L, Falini B, Erber WN, et al. Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984; 32: 219–29
- Beljaards R C, Kaudewitz P, Berti E, et al. Primary cutaneous CD30-positive large cell lymphomas: definition of a new type of cutaneous lymphoma with a favorable prognosis. A European multicenter study of 47 patients. Cancer 1993; 71: 2097–104
- Krishnana J, Tomaszewski M M, Kao GF. Primary cutaneous CD30-positive anaplastic large cell lymphoma. Report of 27 cases. J Cutan Pathol 1993; 20: 193–202
- Rijlaarsdam J U, Huijgens P C, Beljaards RC, et al. Oral etoposide in the treatment of cutaneous large-cell lymphomas. A preliminary report of four cases. Br J Dermatol 1992; 127: 524–8
- Suarez Fernandez R, Lopez Bran E, Nunez Alonso C, et al. Primary cutaneous Ki-1+ large cell lymphoma. Report of a case. Skin Cancer 1994; 9: 209–13
- Penny R J, Blaustein J C, Longtine JA. Ki-1-positive large cell lymphomas, a heterogeneous group of neoplasms. Morphologic, immunophenotypic, genotypic, and clinical features of 24 cases. Cancer 1991; 68: 362–73
- Rubin P, Siemann D. Principles of radiation oncology and cancer radiotherapy. Clinical oncology. A multidisciplinary approach., P Rubin, RF Bakemeier, SK Krackov. American Cancer Society: University of Rochester, New York 1983; 58